Anti-TRPM1 antibody in the serum of autoimmune retinopathy patients

Anti-TRPM1 antibody in the serum of autoimmune retinopathy patients - Anti-TRPM1 antibody in retinopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030852

Enrollment

Registered

2018-01-18

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune retinopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: autoimmune retinopathy patients with bipolar cell function abnormality

Exclusion criteria

Exclusion criteria: nothing paticular

Design outcomes

Primary

Measure	Time frame
Patients posses anti transient receptor potential melastatin 1 (TRPM1) antibody or not	—

Countries

Japan

Contacts

Public ContactUeno Shinji

Nagoya University hospital ophthalmology

ueno@med.nagoya-u.ac.jp052-744-2275

Outcome results